Inflammatory bowel disease (IBD) is a term that refers to two inflammatory conditions, including Crohn鈥檚 disease and ulcerative colitis. Approximately 1.6 million Americans suffer from IBD, most likely to be seen in patients between the ages of 15 and 30.
At BOB体育, we take even the most difficult to treat, complex cases for the full-range of IBD, including:
Our multidisciplinary team is committed to improving the lives of individuals suffering from inflammatory bowel diseases by providing the highest level of personalized patient care, advancing research and discovering innovative treatment options through our numerous clinical trials. Together, we bring together decades of digestive disease expertise from a wide range of clinical specialties.
We are dedicated to discovering new, more effective ways to diagnose and treat the full spectrum of digestive disease through leading-edge research and clinical trials. Patients benefit from the most advanced treatments available and the expertise of our clinician scientists.
To learn more about clinical trials currently being offered or to request a consult, please call (352) 265-8971
Our care team is comprised of board-certified gastroenterologists, colorectal surgeons, rheumatologists, a pharmacist and dedicated triage nurses, along with our endoscopists, dietitians, pathologists and clinical psychologists with expertise in dealing with inflammatory disorders.
Want to know more? Check out our Patient Education section for more information.
BOB体育 research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). The purpose of this study is to assess how safe and effective lutikizumab is in adult鈥�
Colorectal cancer ranks as the second leading cause of cancer-related deaths in the United States. Referred to as a 鈥渟ilent killer鈥� due to its lack of鈥�
June 23, 2023
JUPITER, Fla. 鈥� Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions with limited treatment鈥�
The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
It鈥檚 enough of a problem living with the inconveniences of inflammatory bowel disease. Forms of this condition, like Crohn鈥檚 disease and ulcerative colitis, both cause emergency trips to the...
It鈥檚 enough of a problem living with the inconveniences of inflammatory bowel disease. Forms of this condition, like Crohn鈥檚 disease and ulcerative colitis, both cause emergency trips to the...